CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,000 | -40.6% | 16,000 | -11.1% | 0.02% | -45.5% |
| Q2 2022 | $32,000 | -25.6% | 18,000 | -16.3% | 0.03% | -15.4% |
| Q1 2022 | $43,000 | -25.9% | 21,500 | 0.0% | 0.04% | -23.5% |
| Q4 2021 | $58,000 | -71.4% | 21,500 | -52.7% | 0.05% | -71.5% |
| Q3 2021 | $203,000 | -23.1% | 45,500 | 0.0% | 0.18% | -22.5% |
| Q2 2021 | $264,000 | – | 45,500 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |